BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 860726)

  • 1. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
    Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
    Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complement abnormalities of lipodystrophy.
    Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
    N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interrelationship between hypocomplementaemia, partial lipodystrophy and mesangiocapillary glomerulonephritis.
    Wakefield MA
    Postgrad Med J; 1976 Oct; 52(612):651-2. PubMed ID: 995791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia.
    Peters DK; Charlesworth JA; Sissons JG; Williams DG; Boulton-Jones JM; Evans DJ; Kourilsky O; Morel-Maroger L
    Lancet; 1973 Sep; 2(7828):535-8. PubMed ID: 4125297
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement and mesangiocapillary glomerulonephritis role of complement deficiency in the pathogenesis of nephritis.
    Peters DK; Williams DG
    Nephron; 1974; 13(3):188-97. PubMed ID: 4278792
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic lupus erythematosus in a patient with partial lipodystrophy.
    Font J; Herrero C; Bosch X; Cervera R; Ingelmo M; Mascaró JM
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 2):337-40. PubMed ID: 2303589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.
    Levy Y; George J; Yona E; Shoenfeld Y
    Immunol Res; 1998 Aug; 18(1):55-60. PubMed ID: 9724849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK; Williams DG
    Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Membranoproliferative nephritis and C3NeF.
    N Engl J Med; 1976 Jun; 294(23):1293-5. PubMed ID: 1264160
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the classic complement pathway in patients with the C3 nephritic factor.
    McLean RH; Siegel NJ; Kashgarian M
    Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranoproliferative glomerulonephritis, type II and partial lipodystrophy in an adult.
    Pollock J; Wood B; Kelly JP
    Am J Kidney Dis; 1986 Oct; 8(4):274-6. PubMed ID: 3766535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nephritic factor as an immunoglobulin.
    Williams DG; Bartlett A; Duffus P
    Clin Exp Immunol; 1978 Sep; 33(3):425-9. PubMed ID: 104814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of the complement system in lipodystrophy.
    Ipp MM; Minta JO; Gelfand EW
    Clin Immunol Immunopathol; 1977 Mar; 7(2):281-7. PubMed ID: 862255
    [No Abstract]   [Full Text] [Related]  

  • 17. [Partial lipodystrophy (cephalothoracic type) with asymptomatic dense deposit disease (author's transl)].
    Houssin A; Saint-André JP; Buzelin F; Guenel J
    Ann Med Interne (Paris); 1981; 132(1):44-7. PubMed ID: 7224470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?
    Davis AE; Arnaout MA; Alper CA; Rosen FS
    N Engl J Med; 1977 Jul; 297(3):144-5. PubMed ID: 865586
    [No Abstract]   [Full Text] [Related]  

  • 19. [Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].
    Martínez Debora MJ; Vázquez Martul M; Ecija Peiró JL; González Pérez J; Lirio Rodríguez J; González Mediero I
    An Esp Pediatr; 1989 Jun; 30(6):499-502. PubMed ID: 2679278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesangiocapillary glomerulonephritis associated with meningococcal meningitis, C3 nephritic factor and persistently low complement C3 and C5.
    Hulton SA; Risdon RA; Dillon MJ
    Pediatr Nephrol; 1992 May; 6(3):239-43. PubMed ID: 1616831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.